Evidence map›Paper›PMID 20975081›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2010

Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats.

Annie J Kruger, Chaoxing Yang, Sun W Tam, Douglas Hinerfeld, James E Evans, Karin M Green, John Leszyk, Kejian Yang, Dennis L Guberski, John P Mordes and 3 more

Abstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. The Serum and Saliva Proteome of Dogs with Diabetes Mellitus.Animals : an open access journal from MDPI · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. High abundant protein removal from rodent blood for biomarker discovery.Biochemical and biophysical research communications · 2014
    Article
  8. Article
  9. Article
  10. Acute phase proteins in animals.Progress in molecular biology and translational science · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Annie J KrugerDiabetes Division, University of Massachusetts, Worcester, MA 01605, USA.
Chaoxing Yang
Sun W Tam
Douglas Hinerfeld
James E Evans
Karin M Green
John Leszyk
Kejian Yang
Dennis L Guberski
John P Mordes
Dale L Greiner
Aldo A Rossini
Rita Bortell
Diabetes Australia · AUUniversity of Massachusetts Chan Medical School · USBiomedical Research Models (United States) · USJackson Laboratory · US

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Adaptive immunity in virus-induced diabetes in BBDR ratsU01AI073871 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 2006 to 2011
$2.9M
NIAID NIH HHS AI073871NIAID NIH HHS U01 AI073871NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520
6 · The paper itself

Abstract

Proteomic profiling of serum is a powerful technique to identify differentially expressed proteins that can serve as biomarkers predictive of disease onset. In this study, we utilized two-dimensional (2D) gel analysis followed by matrix-assisted-laser desorption/ionization time-of-flight mass spectrometry analysis to identify putative serum biomarkers for autoimmune type 1 diabetes (T1D) in biobreeding diabetes resistant (BBDR) rats induced to express the disease. Treatment with toll-like receptor 3 ligand, polyinosinic:polycytidilic acid (pIC), plus infection with Kilham rat virus (KRV), a rat parvovirus, results in nearly 100% of young BBDR rats becoming diabetic within 11-21 d. Sera collected from prediabetic rats at early time points following treatment with pIC + KRV were analyzed by 2D gel electrophoresis and compared with sera from control rats treated with phosphate-buffered saline, pIC alone or pIC + H1, a non-diabetogenic parvovirus. None of the latter three control treatments precipitates T1D. 2D gel analysis revealed that haptoglobin, an acute phase and hemoglobin scavenger protein, was differentially expressed in the sera of rats treated with pIC + KRV relative to control groups. These results were confirmed by Western blot and enzyme-linked immunosorbent assay studies, which further validated haptoglobin levels as being differentially increased in the sera of pIC + KRV-treated rats relative to controls during the first week following infection. Early elevations in serum haptoglobin were also observed in LEW1.WR1 rats that became diabetic following infection with rat cytomegalovirus. The identification and validation of haptoglobin as a putative serum biomarker for autoimmune T1D in rats now affords us the opportunity to test the validity of this protein as a biomarker for human T1D, particularly in those situations where viral infection is believed to precede the onset of disease.

Indexed as

AnimalsBiomarkersBlotting, WesternDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Electrophoresis, Gel, Two-DimensionalEnzyme-Linked Immunosorbent AssayFemaleHaptoglobinsMaleParvovirusPoly I-CRatsRats, Inbred LewRats, Inbred StrainsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBiomarkersHaptoglobinsPoly I-C

Identifiers

PMID20975081
PMCPMC4172443
OpenAlexW2154297030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.